CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2020—Agilent Technologies introduced three microarrays to meet the needs of cytogenetic laboratories conducting prenatal and postnatal research.
The Agilent GenetiSure Cyto microarrays include updated, clinically relevant content from respected databases, the company says. The probes on the Cyto microarrays provide high-resolution detection of copy number variations and copy-neutral loss of heterozygosity associated with developmental delay, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dysmorphic features in constitutional DNA samples.
Pages: 1 2